Is P3 Health Stock a Good Investment?
P3 Health Investment Advice | PIIIW |
- Examine P3 Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research P3 Health's leadership team and their track record. Good management can help P3 Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact P3 Health's business and its evolving consumer preferences.
- Compare P3 Health's performance and market position to its competitors. Analyze how P3 Health is positioned in terms of product offerings, innovation, and market share.
- Check if P3 Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about P3 Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in P3 Health Partners stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if P3 Health Partners is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine P3 Health Stock
Researching P3 Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 1.34. P3 Health Partners had not issued any dividends in recent years.
To determine if P3 Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding P3 Health's research are outlined below:
| P3 Health Partners generated a negative expected return over the last 90 days | |
| P3 Health Partners has high historical volatility and very poor performance | |
| P3 Health Partners has some characteristics of a very speculative penny stock | |
| P3 Health Partners has high likelihood to experience some financial distress in the next 2 years | |
| P3 Health Partners has accumulated 121.94 M in total debt. P3 Health Partners has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 1.27 B. Net Loss for the year was (57.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| P3 Health Partners has accumulated about 4.34 M in cash with (76.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| P3 Health Partners has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Some P3 Health Partners Inc. Analysts Just Made A Major Cut To Next Years Estimates - Simply Wall St |
P3 Health Quarterly Long Term Debt |
|
P3 Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.30) | (0.31) | |
| Return On Capital Employed | (0.30) | (0.31) | |
| Return On Assets | (0.07) | (0.07) | |
| Return On Equity | (0.41) | (0.43) |
Determining P3 Health's profitability involves analyzing its financial statements and using various financial metrics to determine if P3 Health is a good buy. For example, gross profit margin measures P3 Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of P3 Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in P3 Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of P3 Health Partners. Check P3 Health's Beneish M Score to see the likelihood of P3 Health's management manipulating its earnings.
Evaluate P3 Health's management efficiency
The company has return on total asset (ROA) of (0.1202) % which means that it has lost $0.1202 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4125) %, meaning that it generated substantial loss on money invested by shareholders. P3 Health's management efficiency ratios could be used to measure how well P3 Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.31 in 2024. Return On Capital Employed is likely to drop to -0.31 in 2024. At this time, P3 Health's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 806.1 M in 2024, whereas Intangible Assets are likely to drop slightly above 601 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.57 | 4.34 | |
| Tangible Book Value Per Share | (2.46) | (2.58) | |
| Enterprise Value Over EBITDA | (2.59) | (2.72) | |
| Price Book Value Ratio | 0.87 | 0.83 | |
| Enterprise Value Multiple | (2.59) | (2.72) | |
| Price Fair Value | 0.87 | 0.83 | |
| Enterprise Value | 278.5 M | 398.5 M |
The operational strategies employed by P3 Health management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Beta 1.14 |
Basic technical analysis of PIIIW Stock
As of the 29th of November, P3 Health owns the market risk adjusted performance of (0.01), and Standard Deviation of 25.2. In connection with fundamental indicators, the technical analysis model allows you to check timely technical drivers of P3 Health Partners, as well as the relationship between them. Please check P3 Health Partners standard deviation, as well as the relationship between the value at risk and kurtosis to decide if P3 Health Partners is priced favorably, providing market reflects its prevailing price of 0.0108 per share. As P3 Health Partners appears to be a penny stock we also advise to check out its total risk alpha numbers.P3 Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific P3 Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on P3 Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases P3 Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chicago Pacific Founders Ugp Iii, Llc over a month ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 2.628 subject to Rule 16b-3 | ||
Chicago Pacific Founders Ugp Iii, Llc over three months ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 3.009 subject to Rule 16b-3 | ||
Chicago Pacific Founders Ugp Iii, Llc over three months ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 3.2417 subject to Rule 16b-3 | ||
Chicago Pacific Founders Ugp Iii, Llc over six months ago Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 2.628 subject to Rule 16b-3 | ||
Bacchus Amir over six months ago Acquisition by Bacchus Amir of 3758130 shares of P3 Health at 375.81 subject to Rule 16b-3 | ||
Hudson Vegas Investment Spv, Llc over six months ago Disposition of 43974331 shares by Hudson Vegas Investment Spv, Llc of P3 Health subject to Rule 16b-3 |
Understand P3 Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing P3 Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0133 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 16.0 | |||
| Semi Deviation | 20.15 | |||
| Downside Deviation | 28.51 | |||
| Coefficient Of Variation | 21262.35 | |||
| Standard Deviation | 25.2 | |||
| Variance | 635.06 | |||
| Information Ratio | (0.0003) | |||
| Jensen Alpha | 0.8515 | |||
| Total Risk Alpha | (3.69) | |||
| Sortino Ratio | (0.0002) | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 146.05 | |||
| Value At Risk | (43.60) | |||
| Potential Upside | 33.7 | |||
| Downside Variance | 812.62 | |||
| Semi Variance | 406.19 | |||
| Expected Short fall | (25.26) | |||
| Skewness | 0.7704 | |||
| Kurtosis | 2.83 |
| Risk Adjusted Performance | 0.0133 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 16.0 | |||
| Semi Deviation | 20.15 | |||
| Downside Deviation | 28.51 | |||
| Coefficient Of Variation | 21262.35 | |||
| Standard Deviation | 25.2 | |||
| Variance | 635.06 | |||
| Information Ratio | (0.0003) | |||
| Jensen Alpha | 0.8515 | |||
| Total Risk Alpha | (3.69) | |||
| Sortino Ratio | (0.0002) | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 146.05 | |||
| Value At Risk | (43.60) | |||
| Potential Upside | 33.7 | |||
| Downside Variance | 812.62 | |||
| Semi Variance | 406.19 | |||
| Expected Short fall | (25.26) | |||
| Skewness | 0.7704 | |||
| Kurtosis | 2.83 |
Consider P3 Health's intraday indicators
P3 Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of P3 Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
P3 Health time-series forecasting models is one of many P3 Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary P3 Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
PIIIW Stock media impact
Far too much social signal, news, headlines, and media speculation about P3 Health that are available to investors today. That information is available publicly through PIIIW media outlets and privately through word of mouth or via PIIIW internal channels. However, regardless of the origin, that massive amount of PIIIW data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of P3 Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of P3 Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to P3 Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive P3 Health alpha.
P3 Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards P3 Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
P3 Health Corporate Management
| Unmesh Srivastava | Chief Officer | Profile | |
| BSN CRNI | Chief Staff | Profile | |
| Leslie Fisher | General Affairs | Profile | |
| Kassi APR | Culture Communications | Profile | |
| Todd MHA | Chief Officer | Profile | |
| Eric Atkins | Chief Officer | Profile |
Additional Tools for PIIIW Stock Analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.